Achieving strong gene editing results is only the first step toward successful non-viral cell therapies. Long-term success depends on developing processes that consistently deliver high-quality cells, support scalability, and translate effectively into manufacturing environments.
In this webinar, we explore the key considerations for building scalable non-viral gene editing workflows for cell therapy applications using the 4D-Nucleofector
® LV Unit PRO.
Rahul Purohit, PhD, Global Technical Specialist, Lonza, examines:
- Strategies for gene delivery
- Best practices for maintaining critical quality attributes such as cell viability and expansion
- How to make processes more scalable, from early development through to GMP manufacturing
Please fill out the form on the right. We hope you will enjoy the webinar!
HeadlineBlock(2)
This is a wonderful headline
Lorem Ipsum dolor Consecteur adipiscing elit
Consecteur adipiscing elit
Text(2)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
HeadlineBlock(3)
This is a wonderful headline
Lorem Ipsum dolor Consecteur adipiscing elit
Consecteur adipiscing elit
Text(3)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
HeadlineBlock(4)
This is an absolute fabulous headline
WideImg & Text (4)
Text(4)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
Feat.Guest(1)
Heading H2
Heading H3
Heading H4
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim.
Feat.Guest(2)
Heading H2
Heading H3
Heading H4
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim.